These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 16936327

  • 21. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ, Weaver AL, Polis AB, Petruschke RA, Geba GP, VACT-1 and VACT-2 (Protocols 106 and 150) Study Groups.
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [Abstract] [Full Text] [Related]

  • 22. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P, Koncz T, Pan S, Lowry S.
    Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
    Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, Castro R, Sanchez M, Detora LM, Ng J.
    Curr Med Res Opin; 2002 Jan; 18(2):49-58. PubMed ID: 12017209
    [Abstract] [Full Text] [Related]

  • 24. A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis.
    Lee M, Yoo J, Kim JG, Kyung HS, Bin SI, Kang SB, Choi CH, Moon YW, Kim YM, Han SB, In Y, Choi CH, Kim J, Lee BK, Cho S.
    Clin Orthop Surg; 2017 Dec; 9(4):439-457. PubMed ID: 29201297
    [Abstract] [Full Text] [Related]

  • 25. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
    Luyten FP, Geusens P, Malaise M, De Clerck L, Westhovens R, Raeman F, Vander Mijnsbrugge D, Mathy L, Hauzeur JP, De Keyser F, Van den Bosch F.
    Ann Rheum Dis; 2007 Jan; 66(1):99-106. PubMed ID: 16815864
    [Abstract] [Full Text] [Related]

  • 26. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
    Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ, Protocol 007 Study Group.
    Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
    [Abstract] [Full Text] [Related]

  • 27. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B.
    Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
    [Abstract] [Full Text] [Related]

  • 28. Clinical use and pharmacological properties of selective COX-2 inhibitors.
    Shi S, Klotz U.
    Eur J Clin Pharmacol; 2008 Mar; 64(3):233-52. PubMed ID: 17999057
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
    Schnitzer TJ, Ekman EF, Spierings EL, Greenberg HS, Smith MD, Brown MT, West CR, Verburg KM.
    Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
    [Abstract] [Full Text] [Related]

  • 30. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, Bliddal H, Uebelhart D, Adami S, Navarro F, Lee A, Moore A, Gimona A.
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [Abstract] [Full Text] [Related]

  • 31. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
    Smugar SS, Schnitzer TJ, Weaver AL, Rubin BR, Polis AB, Tershakovec AM.
    Curr Med Res Opin; 2006 Jul; 22(7):1353-67. PubMed ID: 16834834
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
    Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S.
    Ann Rheum Dis; 2007 Sep; 66(9):1178-83. PubMed ID: 17363401
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ, Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group.
    JAMA; 2002 Jan 02; 287(1):64-71. PubMed ID: 11754710
    [Abstract] [Full Text] [Related]

  • 34. Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.
    Baraf HS, Fuentealba C, Greenwald M, Brzezicki J, O'Brien K, Soffer B, Polis A, Bird S, Kaur A, Curtis SP, EDGE Study Group.
    J Rheumatol; 2007 Feb 02; 34(2):408-20. PubMed ID: 17304660
    [Abstract] [Full Text] [Related]

  • 35. Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.
    Huang WN, Tso TK.
    Bosn J Basic Med Sci; 2018 Feb 20; 18(1):87-94. PubMed ID: 28954205
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, Litschig S, Sloan VS.
    Curr Med Res Opin; 2005 Apr 20; 21(4):517-26. PubMed ID: 15899100
    [Abstract] [Full Text] [Related]

  • 37. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC.
    Ann Med; 2011 Dec 20; 43(8):594-605. PubMed ID: 22017620
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial.
    Gordo AC, Walker C, Armada B, Zhou D.
    J Int Med Res; 2017 Feb 20; 45(1):59-74. PubMed ID: 28222627
    [Abstract] [Full Text] [Related]

  • 39. Treatment of osteoarthritis with continuous versus intermittent celecoxib.
    Strand V, Simon LS, Dougados M, Sands GH, Bhadra P, Breazna A, Immitt J.
    J Rheumatol; 2011 Dec 20; 38(12):2625-34. PubMed ID: 22045833
    [Abstract] [Full Text] [Related]

  • 40. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.